IMAB362
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for IMAB362, covering 2024-11-14 to 2025-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric Cancer [Phase 2]